Stay updated on GM T-cell Therapy in AML/BPDCN Clinical Trial

Sign up to get notified when there's something new on the GM T-cell Therapy in AML/BPDCN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GM T-cell Therapy in AML/BPDCN Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The clinical trial record for CD123-directed CAR T-cell therapy in acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm is displayed, including study design, participant criteria, and outcome measures.
    Difference
    69%
    Check dated 2026-11-08T11:25:43.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden message instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T12:21:09.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The record now presents details of a phase I CD123 CAR T-cell immunotherapy study, including its treatment plan, eligibility criteria, outcome measures, collaborators, and current recruitment status.
    Difference
    71%
    Check dated 2026-10-25T12:37:07.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T12:14:46.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer’s site revision changes from v3.7.0 to v3.7.1, while the 403 error page remains otherwise unchanged.
    Difference
    0.2%
    Check dated 2026-10-11T13:39:43.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details, with a minimal header/footer visible, indicating the content is currently inaccessible.
    Difference
    22%
    Check dated 2026-09-20T10:32:46.000Z thumbnail image

Stay in the know with updates to GM T-cell Therapy in AML/BPDCN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GM T-cell Therapy in AML/BPDCN Clinical Trial page.